Search results for "Diabetes"
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Temporary weight management programs may have long-term cardiometabolic benefits
Trial participants who completed behavioral weight management programs had long-term reductions in systolic blood pressure, cholesterol levels, and HbA1c level relative to comparators, but weight regain reduced these differences over time, a systematic review and meta-analysis found.
https://immattersacp.org/weekly/archives/2023/04/04/2.htm
4 Apr 2023
Patients with diabetes facing vision loss at ever-earlier ages
Just as diabetes is affecting younger populations, so are its consequences. Childhood obesity can translate into diabetic retinopathy in patients in their 20s, which requires a response from the primary care community.
https://immattersacp.org/archives/2013/04/diabetes.htm
1 Apr 2013
New trials provide data to improve medication management in hypertension
A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.
https://immattersacp.org/weekly/archives/2022/10/18/6.htm
18 Oct 2022
Individualize behavioral counseling in those without CVD risk factors, USPSTF says
In an update consistent with its 2017 recommendation, the U.S. Preventive Services Task Force (USPSTF) recommended that clinicians individualize the use of behavioral counseling interventions to promote a healthy diet and physical activity in adults without risk factors for cardiovascular disease (CVD).
https://immattersacp.org/weekly/archives/2022/08/02/4.htm
2 Aug 2022
ACE inhibitors, ARBs most effective against ESRD in patients with diabetes, kidney disease
However, no regimen to lower blood pressure seems to prolong survival, a recent analysis has found.
https://immattersacp.org/weekly/archives/2015/06/02/1.htm
2 Jun 2015
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
No additional benefit seen for self-monitored blood glucose with community health worker support
In a small trial, patients with insulin-treated diabetes were randomly assigned to usual care, a lottery incentive for daily self-monitored blood glucose, or the lottery plus support from a community health worker if needed.
https://immattersacp.org/weekly/archives/2022/05/24/2.htm
24 May 2022
MKSAP quiz: Appropriate treatment for primary hyperaldosteronism
A 67-year-old man is evaluated during a follow-up visit for resistant hypertension. He was recently evaluated for primary hyperaldosteronism, and the screening plasma aldosterone concentration/plasma renin activity ratio was >20. A dedicated adrenal CT scan showed diffuse bilateral adrenal hyperplasia. After history and physical, cardiac and pulmonary exams, and discussion of patient preferences, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2022/07/19/3.htm
19 Jul 2022